EPMT Stock Overview
PT Enseval Putera Megatrading Tbk., together with its subsidiaries, engages in the distribution and supply of pharmaceutical products in Indonesia.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 4/6 |
PT Enseval Putera Megatrading Tbk. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | Rp2,260.00 |
52 Week High | Rp3,200.00 |
52 Week Low | Rp2,250.00 |
Beta | -0.19 |
1 Month Change | -6.61% |
3 Month Change | -13.41% |
1 Year Change | -22.60% |
3 Year Change | -1.74% |
5 Year Change | -5.44% |
Change since IPO | 1,331.32% |
Recent News & Updates
Recent updates
Shareholder Returns
EPMT | ID Healthcare | ID Market | |
---|---|---|---|
7D | -2.6% | 2.9% | 1.7% |
1Y | -22.6% | 3.9% | 3.7% |
Return vs Industry: EPMT underperformed the ID Healthcare industry which returned 3.9% over the past year.
Return vs Market: EPMT underperformed the ID Market which returned 3.7% over the past year.
Price Volatility
EPMT volatility | |
---|---|
EPMT Average Weekly Movement | 1.9% |
Healthcare Industry Average Movement | 5.1% |
Market Average Movement | 5.3% |
10% most volatile stocks in ID Market | 12.2% |
10% least volatile stocks in ID Market | 2.4% |
Stable Share Price: EPMT has not had significant price volatility in the past 3 months.
Volatility Over Time: EPMT's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1973 | 5,115 | Jos Atmadjaja | www.enseval.com |
PT Enseval Putera Megatrading Tbk., together with its subsidiaries, engages in the distribution and supply of pharmaceutical products in Indonesia. The company operates through Pharmaceutical, Consumer Products, and Others segments. It also trades in medical and laboratory equipment and supplies; operates drug stores and health care clinics.
PT Enseval Putera Megatrading Tbk. Fundamentals Summary
EPMT fundamental statistics | |
---|---|
Market cap | Rp6.12t |
Earnings (TTM) | Rp697.12b |
Revenue (TTM) | Rp29.24t |
8.8x
P/E Ratio0.2x
P/S RatioIs EPMT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
EPMT income statement (TTM) | |
---|---|
Revenue | Rp29.24t |
Cost of Revenue | Rp26.34t |
Gross Profit | Rp2.90t |
Other Expenses | Rp2.21t |
Earnings | Rp697.12b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 257.37 |
Gross Margin | 9.92% |
Net Profit Margin | 2.38% |
Debt/Equity Ratio | 1.8% |
How did EPMT perform over the long term?
See historical performance and comparison